LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, announced today that its Venezuelan operating subsidiary, LATAMEDAI VE, has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. The module is designed to improve access to IVIC's laboratory and scientific services, potentially transforming how institutional and business users interact with these critical resources.
The collaboration aims to design, develop, test, and implement a digital interface that will allow authorized users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete payment-related processes. This centralized digital workflow is intended to serve organizations in healthcare, pharmaceuticals, food production, agriculture, and related industries, where access to scientific services is often fragmented and inefficient.
Under the agreement, LataMed AI will work with IVIC to define functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. The parties will also establish robust procedures for handling, transmitting, storing, and accessing laboratory-related information, ensuring compliance with technical, operational, security, and legal standards.
The proposed platform functionality may include electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports. However, the final functionality, implementation schedule, and scope of services remain subject to continued technical development, testing, and approval by both parties.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI, commented, "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
Management believes this initiative could expand LataMed AI's capabilities beyond patient-facing telemedicine, demonstrating how its technology can support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. This aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, and other ecosystem participants.
If successfully implemented, the module could provide a framework adaptable for other institutional and enterprise service environments across Latin America. However, any future expansion would depend on separate agreements, technical readiness, regulatory requirements, and the needs of participating institutions.
The agreement establishes the collaboration framework but does not guarantee a specific implementation date, user adoption level, service volume, revenue, or profitability. The company will provide updates as development progresses. For more information, visit LataMed AI's website or review filings with the U.S. Securities and Exchange Commission at www.sec.gov.
